Raydiant Oximetry

Raydiant Oximetry Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Series A1
  • Latest Deal Amount
  • $1.1M
Latest Deal Amount
  • Investors
  • 16

Raydiant Oximetry General Information

Description

Developer of a non-invasive medical device designed to deliver healthy babies and prevent cesarean section issues. The company's medical device measures the baby's actual oxygen levels during labor and delivery using improved fetal monitoring during childbirth, enabling clinicians to reduce the risk of birth injury and over-intervention as well as decrease healthcare costs and disparities.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Surgical Devices
Primary Office
  • San Ramon, CA 94040
  • United States
+1 (650) 000-0000

Raydiant Oximetry Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Raydiant Oximetry Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Early Stage VC (Series A1) 06-Mar-2020 $1.1M 00.000 0000 Completed Clinical Trials - Phase 1
8. Grant 30-Sep-2019 00000 00.000 Completed Clinical Trials - Phase 1
7. Early Stage VC 10-Sep-2019 00.000 00.000 000.00 Completed Clinical Trials - Phase 1
6. Early Stage VC (Series A) 07-May-2019 00.00 00.00 00.00 Completed Clinical Trials - Phase 1
5. Seed Round 21-Aug-2018 000 00.00 Completed Startup
4. Grant 02-Jul-2018 00000 00000 Completed Startup
3. Accelerator/Incubator 00000 Completed Startup
2. Accelerator/Incubator $100K $105K Completed Startup
1. Accelerator/Incubator 01-Jan-2016 $5K $5K 00000 Completed Startup

Raydiant Oximetry Cap Table

To view Raydiant Oximetry‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000

Raydiant Oximetry Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Luciole Medical Venture Capital-Backed Zurich, Switzerland 000.00 00000000000 000.00
000000000 Private Equity-Backed Taipei, Taiwan 0000 00 000000
00000 Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
00000 0000000 Formerly PE-Backed Plymouth, MN 000000 - 000
0000-00000 00000 Corporate Backed or Acquired Branford, CT 00 000.00 000000&0 000.00

Raydiant Oximetry Executive Team (7)

Name Title Board Seat Contact Info
Neil Ray MD Founder, Chief Executive Officer and Board Member
Russ DeLonzor Chief Operating Officer
Rodney Chin Chief Scientific Officer
Mark Rosen MD Chief Medical Officer

3 Former Executives

Raydiant Oximetry Board Members (5)

Name Representing Role Since
Charles McDonald Raydiant Oximetry Board Member 000 0000
Debra Reisenthel Self Board Member 000 0000
John Maroney Raydiant Oximetry Board Member 000 0000
Neil Ray MD Raydiant Oximetry Founder, Chief Executive Officer and Board Member 000 0000
Terri Burke Raydiant Oximetry Board Member 000 0000

Raydiant Oximetry Investors (16)

To view Raydiant Oximetry‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Global Health Impact Fund Venture Capital Minority 000 0000 000000 0
Springtide Investments Venture Capital Minority 000 0000 000000 0
Tri-Valley Ventures Venture Capital Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
Avestria Ventures Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial